Section of Urologic Oncology and Dean and Betty Gallo Prostate Cancer Center, The Cancer Institute of New Jersey/Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903, USA.
J Endourol. 2010 Sep;24(9):1457-61. doi: 10.1089/end.2010.0027.
To study the safety and feasibility of robot-assisted radical prostatectomy (RARP) for the surgical management of localized prostate cancer, we analyzed perioperative parameters and the pattern of complications in our patients who underwent RARP.
After the performance of more than 600 RARP over a 4-year period by a single surgeon using the daVinci® robot system at the Cancer Institute of New Jersey/Robert Wood Johnson Medical School, we reviewed the medical records of the first 200 patients retrospectively. All patients were divided into four groups according to the order of case numbers to compare intergroup differences in preoperative characteristics and perioperative parameters. Perioperative complications were determined in all patients, and complications were classified according to the Clavien classification system.
The mean operative time was 212 minutes, and the mean blood loss was 189 mL. The mean length of hospital stay was 1.13 days. Overall, 12% (24 men) experienced various perioperative complications among the 200 patients. Of the total 24 patients, 5 (20.8%) men experienced intraoperative complications, and 19 (79.2%) men showed postoperative complications. Rectal injury occurred in two (8.3%) men, and the injury was repaired primarily using two-layer suture techniques without any sequelae. Three (12.5%) patients had femoral neuropathy, and urinary retention developed in 7 (25.0%) patients. Among our 200 patients, no transfusion was needed intraoperatively and postoperatively. There were nine (4.5%) patients in the Clavien grade I complications category, and another 9 (4.5%) men were classified as grade II complications. Six (3.0%) men had grade IIIb complications, and there were no grade IV or V complications.
In our initial series of RARP procedures, we experienced low morbidity, with the overall complication rate of 12%. After implementing minor modifications, most of the early complications were prevented. Rectal injuries, if recognized intraoperatively, can be repaired primarily.
为了研究机器人辅助根治性前列腺切除术(RARP)治疗局限性前列腺癌的安全性和可行性,我们分析了在新泽西癌症研究所/罗伯特伍德·约翰逊医学院使用达芬奇机器人系统完成的超过 600 例 RARP 手术后,前 200 例患者的围手术期参数和并发症模式。
在一位外科医生使用达芬奇机器人系统完成超过 600 例 RARP 手术后的 4 年内,我们回顾性分析了前 200 例患者的病历。所有患者根据病例号顺序分为四组,以比较组间术前特征和围手术期参数的差异。所有患者均确定围手术期并发症,并根据 Clavien 分类系统对并发症进行分类。
平均手术时间为 212 分钟,平均失血量为 189ml。平均住院时间为 1.13 天。200 例患者中共有 12%(24 例男性)发生各种围手术期并发症。在 24 例总并发症患者中,5 例(20.8%)男性发生术中并发症,19 例(79.2%)男性出现术后并发症。2 例(8.3%)男性发生直肠损伤,采用双层缝合技术进行一期修复,无任何后遗症。3 例(12.5%)患者出现股神经损伤,7 例(25.0%)患者发生尿潴留。在 200 例患者中,术中及术后均无需输血。9 例(4.5%)患者为 Clavien Ⅰ级并发症,另有 9 例(4.5%)男性为 Clavien Ⅱ级并发症。6 例(3.0%)男性为 Clavien Ⅲb 级并发症,无 Ⅳ级或 Ⅴ级并发症。
在我们的 RARP 手术初始系列中,我们的发病率较低,总并发症发生率为 12%。在实施了一些小的改进措施后,大多数早期并发症得到了预防。如果术中发现直肠损伤,可以进行一期修复。